Key points from article :
Including immuno-oncology treatments, antibody delivery, Tau-aggregation inhibitors and mRNA therapies.
Join the club for FREE to access the whole archive and other member benefits.
Key points from article :
Including immuno-oncology treatments, antibody delivery, Tau-aggregation inhibitors and mRNA therapies.
Click on resource name for more details.
Company developing genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.
Company developing drugs for chronic medical conditions relating to abnormalities of bacterial composition.
Company discovering and developing innovative therapeutic and diagnostic solutions targeting liver diseases.
Biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies.